MML Investors Services’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $403K | Buy |
+8,250
| New | +$403K | ﹤0.01% | 2230 |
|
|
2024
Q1 | – | Sell |
-15,295
| Closed | -$422K | – | 2553 |
|
|
2023
Q4 | $422K | Sell |
15,295
-23,907
| -61% | -$660K | ﹤0.01% | 1848 |
|
|
2023
Q3 | $879K | Buy |
39,202
+10,302
| +36% | +$231K | ﹤0.01% | 1292 |
|
|
2023
Q2 | $1.18M | Buy |
28,900
+5,175
| +22% | +$210K | 0.01% | 1155 |
|
|
2023
Q1 | $1.15M | Sell |
23,725
-2,175
| -8% | -$105K | 0.01% | 1002 |
|
|
2022
Q4 | $989K | Sell |
25,900
-1,950
| -7% | -$74.5K | 0.01% | 1156 |
|
|
2022
Q3 | $1.4M | Sell |
27,850
-25,900
| -48% | -$1.3M | 0.01% | 900 |
|
|
2022
Q2 | $2.15M | Buy |
53,750
+3,150
| +6% | +$126K | 0.02% | 722 |
|
|
2022
Q1 | $1.89M | Buy |
50,600
+3,425
| +7% | +$128K | 0.01% | 826 |
|
|
2021
Q4 | $1.88M | Buy |
47,175
+2,848
| +6% | +$113K | 0.01% | 794 |
|
|
2021
Q3 | $1.65M | Buy |
44,327
+6,400
| +17% | +$238K | 0.01% | 805 |
|
|
2021
Q2 | $1.6M | Buy |
37,927
+25,900
| +215% | +$1.09M | 0.01% | 799 |
|
|
2021
Q1 | $569K | Buy |
+12,027
| New | +$569K | 0.01% | 1198 |
|
|
2020
Q4 | – | Sell |
-6,127
| Closed | -$286K | – | 1697 |
|
|
2020
Q3 | $286K | Buy |
+6,127
| New | +$286K | ﹤0.01% | 1313 |
|